Recent recalls issued for a class of drugs known as angiotensin II receptor blockers, or ARBs, have led to public concern about the country's sourcing of finished drug products.
Greg Walden: “Recent recalls issued for a class of drugs known as angiotensin II receptor blockers, or ARBs, have led to public…”
Editor's note · Context
Highlighting public concern over drug recalls and sourcing issues.
Share
More from Greg Walden
I believe we had two other speakers planning to come down and speak, but it does not appear they have been able to free themselves from their other business. Mr. Speaker, I encourage us all to support this very strong resolution that our…
I want to make sure that it is a responsible way for all parties, which is why a number of us are very concerned about the administration's recent support of the waiver to release and transfer the IP for the vaccine.
I have said before and I will say it again: I don't think there is a more fierce advocate for consumers than the gentlewoman who chairs the subcommittee. She has, once again, brought solid legislation to the floor. We appreciate her and…
I thank my friend and colleague from Illinois for her support of this legislation and her work on it. Once again, I urge passage of the legislation, and I yield back the balance of my time.





